[Off-label drugs in childhood psoriasis].
Sign Up to like & getrecommendations! Published in 2020 at "Annales de dermatologie et de venereologie"
DOI: 10.1016/j.annder.2020.01.021
Abstract: INTRODUCTION Psoriasis affects 0.5% of children in Europe, with moderate to severe clinical forms in 15-35% of cases warranting the use of systemic treatments. Few treatments are licensed for childhood psoriasis. In this study, we… read more here.
Keywords: label; childhood psoriasis; treatment; study ... See more keywords
Biological treatments for paediatric psoriasis : a retrospective observational study on biological drug survival in daily practice in childhood psoriasis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.15579
Abstract: Three biotherapies – etanercept, adalimumab and ustekinumab – are licensed in childhood psoriasis. The few data available on their efficacy and tolerance are mainly derived from industry trials. However, biological drug survival impacts long‐term performance… read more here.
Keywords: psoriasis; childhood psoriasis; drug survival; biological drug ... See more keywords
Impact of Childhood Psoriasis on Caregivers' Quality of Life, Measured with Family Dermatology Life Quality Index.
Sign Up to like & getrecommendations! Published in 2020 at "Acta dermato-venereologica"
DOI: 10.2340/00015555-3602
Abstract: Psoriasis is a chronic skin disease, that often develops below the age of 18. In an integrated approach to childhood psoriasis, the impact of psoriasis on family members merits consideration. In this study, the impact… read more here.
Keywords: dermatology; childhood psoriasis; impact; psoriasis ... See more keywords